What did Integer Holdings Corp. pay for Aran Biomedical and Proxy Biomedical?

Integer Holdings Corp. acquired Aran Biomedical and Proxy Biomedical for $131.0M in 2022, equivalent to 7.70x revenue. Target revenue was approximately $17.0M.

What does Aran Biomedical and Proxy Biomedical do?

Aran Biomedical and Proxy Biomedical is a medical devices business.

What multiple did Integer Holdings Corp. pay for Aran Biomedical and Proxy Biomedical?

7.70x revenue, based on disclosed deal value of $131.0M and disclosed financials.

M&A TRANSACTION · 2022

Aran Biomedical and Proxy Biomedical acquired by Integer Holdings Corp.

$131.0M· 7.70x revenue

Target

Aran Biomedical and Proxy Biomedical

Acquirer

Integer Holdings Corp.

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$17.0M

EBITDA

—

Deal Value

$131.0M

EV/EBITDA

—

Context

This $131.0M acquisition of Aran Biomedical and Proxy Biomedical by Integer Holdings Corp. sits in the medical devices sub-vertical. Integer Holdings Corp. is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Aran Biomedical and Proxy Biomedical acquisition.

Citation: ExitValue.ai. (2022). Aran Biomedical and Proxy Biomedical acquired by Integer Holdings Corp.. https://exitvalue.ai/deals/aran-biomedical-and-proxy-biomedical-acquired-by-integer-holdings-corp-hc-2022-0064